LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Edwards Lifesciences Corporation Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$80.99M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +1.42% | 13.70K shares | -10.91M | $82.63 | 980.20K |
Q2 2022 | share | Increase | +0.16% | 1.55K shares | -21.68M | $95.09 | 966.49K |
Q1 2022 | share | Increase | +0.22% | 2.14K shares | -11.13M | $117.72 | 964.94K |
Q4 2021 | share | Decrease | -1.72% | -16.81K shares | 13.83M | $130.68 | 962.80K |
Q3 2021 | share | Increase | +0.26% | 2.50K shares | 9.70M | $113.21 | 979.61K |
Q2 2021 | share | Decrease | -0.17% | -1.63K shares | 19.33M | $103.57 | 977.11K |
Q1 2021 | share | Increase | +1.17% | 11.29K shares | -6.39M | $83.64 | 978.74K |
Q4 2020 | share | Increase | +17.68% | 145.37K shares | 22.64M | $91.23 | 967.44K |
Q3 2020 | share | Increase | +63.02% | 317.78K shares | 30.76M | $79.82 | 822.07K |
Q2 2020 | share | Increase | +77.99% | 220.97K shares | 17.03M | $69.11 | 504.28K |
Q1 2020 | share | Increase | +4.11% | 11.19K shares | -3.34M | $62.87 | 283.31K |
Q4 2019 | share | Increase | +2.21% | 5.87K shares | 1.64M | $77.76 | 272.12K |
Q3 2019 | share | Increase | +7.38% | 18.29K shares | 4.24M | $73.3 | 266.25K |
Q2 2019 | share | Increase | +8.31% | 19.03K shares | 669K | $61.58 | 247.95K |
Q1 2019 | share | Increase | +1.83% | 4.10K shares | 3.12M | $63.78 | 228.92K |
Q4 2018 | share | Increase | +3.57% | 7.75K shares | -1.11M | $51.06 | 224.82K |
Q3 2018 | share | Decrease | -1.16% | -2.55K shares | 1.94M | $58.03 | 217.06K |
Q2 2018 | share | Increase | +0.10% | 210 shares | 453K | $48.52 | 219.61K |
Q1 2018 | share | Increase | +435.40% | 178.42K shares | 8.66M | $46.51 | 219.40K |
Q4 2017 | share | Increase | +68.23% | 16.62K shares | 652K | $37.57 | 40.98K |
Q3 2017 | share | Increase | +192.51% | 16.03K shares | 568K | $36.44 | 24.36K |
Q2 2017 | share | Increase | +2.81% | 228 shares | 66K | $39.41 | 8.32K |
Q1 2017 | share | Increase | +575.00% | 6.9K shares | 217K | $31.36 | 8.1K |
Q4 2016 | share | Decrease | -42.86% | -900 shares | -47K | $31.23 | 1.2K |
Q3 2016 | share | 0.00% | 0 shares | 14K | $40.19 | 2.1K | |
Q2 2016 | share | Increase | +133.33% | 1.2K shares | 44K | $33.24 | 2.1K |
Q1 2016 | share | 0.00% | 0 shares | 2K | $29.4 | 900 |